A Pan-Cancer Retrospective Study on the Relationship Between Tumor Microenvironment Composition and Efficacy of Antibody-Based Antitumor Therapy
Clinical trial NCT07584044 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07584044
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-01
- Primary completion
- 2026-06-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.